20 DE Reg 705 03-01-17 - Proposed Public Notice 2500 Board of Pharmacy

Sep 17, 2026

Upload by Blitz

Delaware Department of State, Division of Professional Regulation, 2500 Board of Pharmacy issues a proposed public notice under 24 Del.C. §2506(a)(1) outlining revisions to pharmacy rules and regulations. The notice schedules a public hearing on April 19, 2017, accepts oral and written comments, and specifies submission and record access procedures. It describes changes including biennial continuing education requirements, updates to NAPLEX-related exam rules, revisions to listed substantially related crimes, and standards for compounded medications for human and animal use.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages66

Reading Time2 h 46 min

AccessFree to download

Proposed Public Notice

Public Hearing and Comment Procedures

Summary of Proposed Regulatory Changes

Pharmacist Licensure Requirements

Definitions

DEPARTMENT OF STATE DIVISION OF PROFESSIONAL REGULATION 2500 BOARD OF PHARMACY Statutory Authority: 24 Delaware Code, Section 2506(a)(1) (24 Del.C. §2506(a)(1)) 24 DE Admin. Code 2500 PROPOSED PUBLIC NOTICE 2500 Board of Pharmacy Pursuant to 24 Del.C. §2506(a)(1), the Delaware Board of Pharmacy ("Board") has proposed revisions to its rules and regulations. A public hearing will be held on April 19, 2017 at 9:30 [a.m. in](a.m. in) the second floor conference room A of the Cannon Building, 861 Silver Lake Boulevard, Dover, Delaware, where members of the public can offer comments on the amendments to the rules and regulations. Anyone wishing to receive a copy of the proposed rules and regulations may obtain a copy from the Delaware Board of Pharmacy, 861 Silver Lake Boulevard, Dover, Delaware 19904. Persons wishing to submit written comments may forward these to the Board liaison, Christine Mast, at the above address. The proposed regulations add to subsection 1.4. 1, the biennial licensure renewal requirement that all licensees must complete two hours of continuing education in 1) the distribution, dispensing or delivery of controlled substances, or 2) the detection and recognition of symptoms, patterns of behavior, or other characteristics of impairment and dependency resulting from the abusive or illegal use of controlled substances. Subsection 1.2.4 has been revised to reflect new NAPLEX requirements for taking of the examination. The list of crimes substantially related to the practice of pharmacy, set forth in Section 17.0, has been updated to include amendments to the Uniform Controlled Substances Act. Finally, subsection 5.1.7, pertaining to compounded medications for office use, has been revised to delineate standards for both human use and animal use. The proposed changes allow veterinarians to administer and dispense compounded preparations for animal patients subject to certain specified requirements designed to maintain safety and quality for the protection of the public. In accordance with 29 Del.C. §10118(a), the final date to receive written comments will be May 4, 2017, which is 15 days following the public hearing. The Board will deliberate on all of the public comment at its next regularly scheduled meeting, at which time it will determine whether to adopt the rules and regulations as proposed or make additional changes due to the public comment. 2500 Board of Pharmacy 1.0 Pharmacist Licensure Requirements 1.1 Definitions Words and terms defined in Delaware Code Title 1, Section 302 and Title 24, Section 2502 of the Delaware Code are applicable to these regulations. The following additional words and terms, when used within these regulations, shall have the following meaning unless the context clearly indicates otherwise or an alternate definition has been given: "Automated Data Processing System (ADPS)" means a system utilizing computer software and hardware for the purposes of recordkeeping. "Cell" means any container that holds the medication for automatic dispensing. "Central Prescription Processing" means the processing by a pharmacy of a request from another pharmacy to fill or refill a prescription drug order or to perform processing functions such as dispensing, DUR, claims adjudication, refill authorizations, and therapeutic interventions. "Common Database" means a file or database created by an ADPS that enables authorized users to have common access to this file regardless of physical location. "Compounding" means the art of the extemporaneous preparation and manipulation of drugs as a result of a practitioner's prescription order or initiative based on the practitioner-patient-pharmacist relationship in the course of professional practice, including the preparation of drugs in anticipation of drug orders based on routine, regularly observed prescribing patterns. "Computer" means a programmable electronic device, capable of multifunctions including but not li

FAQs

What authority and purpose support these proposed pharmacy rule revisions?

The notice is issued pursuant to 24 Del.C. §2506(a)(1), stating that the Delaware Board of Pharmacy has proposed revisions to its rules and regulations.

When and where is the public hearing, and how can the public participate?

The public hearing is scheduled for April 19, 2017 at 9:30 a.m. in the second floor conference room A of the Cannon Building, 861 Silver Lake Boulevard, Dover. The notice explains that members of the public may offer comments on the amendments, and written comments may be submitted to the Board liaison at the address provided.

What continuing education and related rule changes are included in the proposed regulations?

The proposed regulations add a biennial licensure renewal requirement requiring all licensees to complete two hours of continuing education covering controlled substance distribution/dispensing/delivery or recognizing impairment and dependency patterns. It also revises subsection 1.2.4 for updated NAPLEX examination requirements and updates other specified subsections including standards for compounded medications for both human and animal use.

Sep 17, 2026

Upload by Blitz